Table 2 The list of characterized off-targets having significant binding efficiency towards gefitinib compared to their respective reported ligands.
S. No. | Name | PDB | Ligand present in co-crystal | gefitinib MM-GBSA binding energy | known ligands MM-GBSA binding energy | ∆Ggef/∆Glig | IC50 (nM) of known ligand |
|---|---|---|---|---|---|---|---|
1 | Cyclin-dependent kinase 2 | 2UZD | C85 | −86.307 | −20.274 | 4.257028707 | ND |
2 | Cyclin-dependent kinase 2 | 2VTQ | LZA | −74.582 | −19.222 | 3.880033295 | ND |
3 | Fibroblast growth factor receptor 2 | 3RI1 | 3RH | −77.977 | −28.889 | 2.699193465 | 180 |
4 | Ephrin type-B receptor 4 | 2×9F | UNN | −83.961 | −38.83 | 2.16227144 | 140 |
5 | STE20-like serine/threonine-protein kinase | 2J51 | DKI | −71.754 | −33.967 | 2.112462096 | 140 |
6 | Mitogen-activated protein kinase 14 | 1WBW | LI4 | −81.464 | −42.498 | 1.916890207 | 2 |
7 | HTH-type transcriptional regulator TtgR | 2UXH | QUE | −100.838 | −55.277 | 1.824230693 | ND |
8 | Serine/threonine-protein kinase pim-1 | 3MA3 | 01I | −89.67 | −50.377 | 1.779978959 | 61 |
9 | Bone morphogenetic protein receptor type-1B | 3MDY | LDN | −78.885 | −44.586 | 1.769277352 | 5000 (Kd) |
10 | Activin receptor type-1 | 3MTF | A3F | −80.671 | −45.83 | 1.760222562 | 614 (Kd) |
11 | Mitogen-activated protein kinase 10 | 2O2U | 738 | −85.273 | −49.501 | 1.722652068 | 400 (Ki) |
12 | Cyclin-dependent kinase 2 | 2IW6 | QQ2 | −80.586 | −51.35 | 1.569347614 | 44000 |
13 | Insulin-like growth factor 1 receptor | 2ZM3 | 575 | −75.531 | −48.801 | 1.547734678 | 22900 |
14 | Cyclin-dependent kinase 2 | 2W17 | I19 | −79.496 | −51.79 | 1.534968141 | 60 |
15 | Serine/threonine-protein kinase Chk1 | 2BRH | DFW | −70.09 | −45.808 | 1.530082082 | 9.7 |
16 | Tyrosine-protein kinase ITK/TSK | 3V8T | 477 | −83.127 | −54.685 | 1.520106062 | 0.3 |